abnormalities in the expression of these genes also play an important role in carcinogenesis (1-3).
The multistage process of carcinogenesis involves the
Following the initial discovery of oncogenes,~20 years ago, progressive acquisition of mutations, and epigenetic it appeared that there might be a small number of such genes. abnormalities in the expression, of multiple genes that have However, since then over 100 oncogenes and at least 12 tumor highly diverse functions. An important group of these genes suppressor genes have been identified, and the list keeps are involved in cell cycle control. Thus, cyclin D1 is growing (5-7). Moreover, a single colon cancer cell frequently frequently overexpressed in a varety of human cancers.
contains defined mutations in multiple genes (four or more) Cylin D1 plays a critical role in carcinogenesis because (i) plus numerous less well defined mutant and/or aberrantly overexpression enhances cell transformation and tumoriexpressed genes, as well as gross chromosomal abnormalities. genesis, and enhances the amplification of other genes, and (ii) an antisense cyclin D1 cDNA reverts the malignant Indeed, in human colon tumors~25% of all loci show loss of phenotype of carcinoma cells. Therefore, cyclin D1 may be heterozygosity, and in cancer cells with defects in DNA a useful biomarker in molecular epidemiology studies, and mismatch repair thousands of loci can be mutated in a single inhibitors of its function may be useful in both cancer cancer cell (6,8,9). Presumably, these widespread changes chemoprevention and therapy. We discovered a paradoxical reflect the deleterious effects of mutagens, both exogenous increase in the cell cycle inhibitors protein p27 Kip1 in and endogenous, as well as various types of genomic instability a subset of human cancers, and obtained evidence for acquired during tumor development. In the subset of familial homeostatic feedback loops between cyclins D1 or E and cancers some of these mutations, usually in tumor suppressor p27 Kip1 . Furthermore, derivatives of HT29 colon cancer genes, are inherited, thus enhancing the multistage process of cells with increased levels of p27 Kip1 showed increased carcinogenesis.
sensitivity to induction of differentiation. This may explain
Because of the large number and diverse functions of why decreased p27 Kip1 in a subset of human cancers is the known oncogenes and tumor suppressor genes we have associated with a high grade (poorly differentiated) histodeveloped a classification scheme which is based on their logy and poor prognosis. Agents that increase cellular levels specific biochemical functions (Table I ) (10). The genes are of p27 Kip1 may, therefore, also be useful in cancer therapy. divided into two broad functional categories, those that control Using an antisense Rb oligonucleotide we obtained intracellular regulatory circuitry and those that influence cell evidence that the paradoxical increase in pRb often seen surface and extracellular functions. The first category is in human colon cancers protects these cells from growth further divided into four subcategories: (1) genes that play a inhibition and apopotosis. On the basis of these, and role in the responses of cells to external growth stimuli other findings, we hypothesize that homeostatic feedback (i.e. genes that encode growth factors, cellular receptors, mechanisms play a critical role in multistage carcinocoupling proteins, and protein kinases that transduce informagenesis. Furthermore, because of their bizarre circuitry, tion across the cytoplasm to the nucleus) and nuclear cancer cells suffer from 'gene addiction' and 'gene hypertranscription factors that then increase or repress the expression sensitivity' disorders that might be exploited in both cancer of specific genes; (2) genes involved in DNA replication and prevention and chemotherapy. repair; (3) genes involved in cell cycle control, including checkpoint functions; and (4) genes that determine cell fate, i.e. cellular differentiation, senescence and programmed cell The current paradigm of multistage carcinogenesis death (apoptosis). Many of the oncogenes, for example ras, are in subcategory 1. Subcategory 2 includes the DNA excision A variety of experimental and clinical studies carried out and mismatch repair genes. Subcategory 3 includes the tumor during the past century established the principle that cancers suppressor genes Rb and p53. Recent studies on cyclins and develop through a multistage process which can encompass cyclin-related genes and their abnormalities in cancer have an appreciable fraction of the lifespan of the species (1-3). Within the past few decades astounding progress has been rapidly expanded this subcategory (11, 12) . This subject is made in our understanding of the cellular, biochemical and discussed in greater detail below. Subcategory 4 includes the molecular genetic events that occur during this multistage bcl-2 family of proteins that regulate apoptosis. This category process. A current paradigm is that this stepwise process is of considerable importance since it is now apparent that the increased proliferation of cancer cells reflects a disturbance in the balance between de novo cell replication and terminal differentiation, senescence and apoptosis, rather than simply increased cell replication. The second category includes genes that influence how cells interact with the extracellular matrix and/or neighboring cells. This category includes various cell surface proteins, cell adhesion molecules, extracellular proteases and angiogenesis factors. Alterations in these genes are especially relevant to tumor cell invasion and metastasis. There are several caveats related to this classification scheme. Thus, some of the above-mentioned genes perform multiple functions that extend across these categories (i.e. p53); there is cross-talk between components in each category and between categories, and the biological effects of some of these genes are dependent upon the context of the specific cell type in which it is expressed, a theme which will be further developed later in this paper. Therefore, the classification scheme shown in Table I is an oversimplification, nevertheless it may provide a useful framework and highlights the diverse functions that are perturbed during carcinogenesis.
Abnormalities in cell cycle control proteins in cancer
Subcategory 3 in Table I represents a recent set of oncogenes and tumor suppressor genes, discovered as a result of the recent elucidation of the specific proteins that normally regulate the cell cycle in a variety of eukaryotic cells. As shown in Figure 1 , the orderly progression of dividing mammalian cells and dysregulated in a variety of human cancers (11,12). Indeed, increased expression of cyclin D1 is one of the most frequent abnormalities in human cancer since it occurs in~60% of of interest that the APC/β-catenin pathway regulates the expression of cyclin D1 (16,17), which may explain why cyclin breast cancers, 40% of colorectal cancers, 40% of squamous carcinomas of the head and neck and 20% of prostate cancers D1 is often overexpressed in colorectal cancers (11, 12, 14) . Amplification and overexpression of CDK4 is also seen in (10-13). Furthermore, increased expression of cyclin D1 can be an early event in carcinogenesis, since it is also seen in human cancers (11, 12) . Abnormalities in the expression of CDIs and in the retinoblastoma (Rb) gene, which plays a precursor lesions of the colon, esophagous and breast (14,15 and unpublished data). It may, therefore, be a useful biomarker crucial role in controlling the G 1 -S transition, are described below. The proteins CDC25A and CDC25B, which are phosin molecular epidemiology and chemoprevention studies. It is phatases that activate cyclin/CDK complexes, are frequently overexpressed in human breast cancers (18), non-small-cell cancers (19) and head and neck cancers (20) . Using an MMTV-CDC25B construct we have developed transgenic mice that overexpress CDC25B in the mammary gland and found that this increases susceptibility to induction of mammary tumors by dimethylbenz[a]anthracene (21) , thus demonstating a synergistic interaction between a carcinogen and a cell cycle control protein in carcinogenesis.
In mechanistic studies we demonstrated that overexpression of cyclin D1 can play a critical role in carcinogenesis since introduction of an antisense cDNA to cyclin D1 into esophageal or colon cancer cells reverts their phenotype towards normal and inhibits tumorigenicity (22, 23) . This finding has been extended by other investigators, to pancreatic (24) and squamous carcinomas (25) . Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with bound to CDKs, stimulate the G 1 -S transition of the cell cycle. At elevated levels they also can induce (through unknown mechanisms) an increase in
We also found that overexpression of cyclin D1 can enhance cellular levels of the p27 Kip1 protein, thus providing feedback inhibition of the process of gene amplification (26) , and this finding has the activities of these cyclins.
been confirmed by others (27) . Therefore, increased expression of cyclin D1 could enhance the process of tumor progression during multistage carcinogenesis, by causing genomic we transfected the MCF7 human breast cancer cell line and the MCF10F human non-tumorigenic mammary epithelial cell instability. Taken together, these findings suggest that drugs that inhibit cyclin D1 expression or activity, or the activity of line with a vector containing the p27 Kip1 cDNA to obtain derivatives that express increased levels of p27 Kip1 (40) . The CDK4, may be useful in cancer chemoprevention or treatment (10,22,23).
increased expression of p27 Kip1 in derivatives of both of these cell lines was associated with lengthening of the G 1 phase, an increase in the doubling time, a decreased saturation density and Paradoxical overexpression of tumor suppressor genes a decreased plating efficiency. In the MCF7 cells, anchorageStudies on p27 Kip1 independent growth and in vivo tumorigenicity were also suppressed. These effects were associated with decreased As discussed above, according to the current paradigm carcinogenesis is associated with activation of oncogenes and cyclin E-associated in vitro kinase activity, in both cell lines. Thus, breast cancer cells are still responsive to p27 Kip1 -decreased expression of tumor suppressor genes. Therefore, we were surprised to find relatively high levels of expression mediated inhibition of cell growth despite the high basal level of this protein. These results suggest that therapeutic strategies of the protein p27 Kip1 in a series of human esophageal cancer cell lines (28) . This protein inhibits cell cycle progresthat further increase the level of expression of p27 Kip1 or mimic its activity might be useful in cancer therapy (40) . sion by binding to and inhibiting the activities of cyclin/ CDK complexes ( Figure 1B) , especially cyclin E/CDK2 and, Curiously, we found that cancer cell lines and tumors that had high levels of p27 Kip1 also frequently had high levels of therefore, it is a putative tumor suppressor gene (29) . In addition, genetically engineered mice with reduced expression cyclin D1 (28, (31) (32) (33) (34) (35) . Furthermore, ectopic overexpression of cyclin D1 in esophageal (28) or mammary epithelial cell of p27 Kip1 display increased sensitivity to carcinogen-induced tumor formation, even if only one allele is inactivated (30) .
lines (31) was associated with increased expression of p27 Kip1 , and when an antisense cyclin D1 cDNA was introduced into We found that several human colon and breast cancer cell lines also express high levels of p27 K1p1 , even during exponeneither esophageal or colon cancer cells to reduce the expression of cyclin D1, this led to reduced levels of the p27 Kip1 tial growth, but this protein is expressed at low levels in three normal human mammary cell lines (31) (32) (33) (34) (35) .
protein (22,23 and unpublished data). We also found that overexpression of cyclin E in mammary epithelial cells is Furthermore, we found that whereas in normal mammary epithelial cells the level of the p27 Kip1 protein varies during associated with increased expression of p27 Kip1 (33, 41) . Taken together, these findings suggest the existence of a feedback the cell cycle, in breast cancer cell lines the level can remain high throughout the cell cycle (34). The high level of p27 Kip1 loop between cyclin D1 or cyclin E and p27 Kip1 , the purpose of which is to maintain a homeostatic balance between positive in these cancer cells is not simply an artefact of cell culture, since we and other investigators have found that p27 Kip1 is and negative regulators of the G 1 -S transition in the cell cycle ( Figure 2 ). The increased levels of p27 Kip1 in cancer cells also expressed at relatively high levels in a subset of primary human breast and colon cancers (34-38). It is also overmight protect these cells from potentially toxic effects of increased expression of cyclin D1 and or cyclin E (10,29). expressed in small-cell carcinomas of the lung, despite their high degree of malignancy (39) .
This regulation of p27 Kip1 appears to occur at a posttranslational level which is consistent with the fact that the The increased expression of p27 Kip1 in cancer cells seems paradoxical, especially because mutations in this gene have regulation of its expression is usually regulated at this level by a ubiquitin-protesome mediated mechanism (29). There is not been found or are extremely rare in various cancers (29) . A possible explanation for the paradoxical increase in p27 Kip1 evidence that one mechanism by which cancer cells are protected from the inhibitory effects of p27 Kip1 is to sequester in some cancer cells is that they have become refractory to the inhibitory effects of this protein. To address this question, this protein in the cytoplasm to prevent it from inhibiting cyclin E/CDK2 in the nucleus. It should be mentioned that at genesis. Thus, during the transition from normal mucosa to low levels of expression p27 Kip1 enhances the formation of adenomatous polyps to carcinomas there was a progressive cyclin-CDK complexes by acting as an assembly factor (29) .
increase in pRb expression. In vitro studies were also done to Although, as discussed above, a subset of human cancers examine the phenotypic effects of an antisense oligodeoxydisplay relatively high levels of the p27 Kip1 protein, including nucleotide (AS-Rb) targeted to Rb mRNA in the HCT116 esophageal, breast, colon and small-cell lung cancers, recent colon carcinoma cell line that expresses a relatively high level studies indicate that another subset of human cancers displays of pRb (44) . Treatment of HC116 cells with AS-Rb decreased decreased expression of this protein, and that this decrease is the level of pRb by~70% and also decreased the levels of the associated with high grade (poorly differentiated) tumors and cyclin D1 protein and cyclin D1-associated kinase activity. an unfavorable prognosis. This association is remarkable since
This finding is consistent with other evidence of the existence it has now been seen in a variety of human cancers including of a feedback regulatory loop between Rb and cyclin D1 carcinomas of the breast, colon, stomach, prostate and oral (44, 45) . A striking finding was that AS-Rb inhibited the growth cavity; as well as non-small cell lung carcinomas, gliomas, of HCT116 cells and induced apoptosis. Reporter assays endocrine tumors and lymphomas (for review see ref. 29) .
indicated an~17-fold increase in E2F activity. Furthermore, Because we found a correlation between the subset of colon we could mimic the growth-inhibitory and apoptosis-inducing cancers with high levels of p27 Kip1 with well and moderately effects of AS-Rb by simply ectopically overexpressing E2F in differentiated carcinomas (35) we wondered if p27 Kip1 played HCT116 cells. These findings suggest that the increased a role in the differentiation of these cancers. Therefore, we expression of pRb in colorectal carcinoma cells may provide examined the effects of stably overexpressing high levels of a homeostatic mechanism that protects them from growth p27 Kip1 in the human colon cancer cell line HT29, which can inhibition and apoptosis, perhaps by counterbalancing the be induced to undergo differentiation in response to treatment potentially toxic effects of excessive E2F. There is, indeed, with sodium butyrate (42) . We found that the p27 Kip1 overevidence that the majority of colon tumors have high E2F expressor clones displayed an increase in the amount of the activity (46) . This could reflect the effects of activating p27 Kip1 protein in cyclin E/CDK2 immunoprecipitates and a mutations in the k-ras oncogene, increased expression of cyclin corresponding decrease in cyclin E-associated kinase activity, D1, or other factors that affect E2F levels and/or activity. when compared with vector control clones, providing evidence
We found that transfection of our As-Rb into WI38 human that the overexpressed protein was functional. Clones with a lung fibroblasts stimulated rather then inhibited growth (44), high level of p27 Kip1 displayed partial growth inhibition in which is consistent with previous evidence that in several cell monolayer culture and a decrease in plating efficiency, even types pRb acts as a growth inhibitor. The seemingly paradoxical though they expressed increased levels of the cyclin D1 protein.
effects found in colon cancer are not unique since there is Using alkaline phosphatase expression as a marker, we found evidence that subsets of human bladder and breast cancers and that the p27 Kip1 overexpressor clones displayed a 2-3-fold leukemias can also display increased expression of pRb, and increase in sensitivity to induction of differentiation by 2 mM that pRb can protect bladder cancer cells, osteosarcoma cells sodium butyrate. In contrast with these results, derivatives of and hepatic carcinoma cells from apoptosis induced by various HT29 cells that stably overexpressed p21 Cip1/Waf1 displayed agents (44, 47) . It is also apparent that, whereas E2F can act decreased sensitivity to the induction of differentiation (42) .
as an oncogene in some cell systems, in others it can induce These results may explain why decreased levels of p27 Kip1 in apoptosis (44, 48) . Thus, the effects of altered expression of certain human cancers are associated with high grade tumors.
pRb and E2F, like that of numerous other oncogenes or tumor They also provide further evidence that therapeutic strategies suppressor genes, is highly context dependent. This subject is that cause an increase in the level of p27 Kip1 may be useful in discussed in greater detail below. The mechanism by which cancer therapy. Since there already exist several agents that pRb expression is upregulated in some human cancers is not can increase the expression of p27 Kip1 in specific cell types, known. It has been suggested that in some cases this may be including TGFβ, IFN-β, IFN-γ, cAMP agonists and rapamycin due to loss of expression of p16 INK4a , since there appears to (29) , in specific cell systems, this approach may be clinically be a homeostatic feedback regulatory loop between pRb and feasible. Furthermore, adenoviral p27 Kip1 gene transfer can p16 INK4a (44, 49, 50) . induce apoptosis in several types of cancer cell lines (for Paradoxical increases in other inhibitors of the cell cycle review see ref. 29).
As described above, the CDI p27 Kip1 is often expressed at relatively high levels in human cancer cells. High levels of Paradoxical increase in the Rb protein in colorectal cancer expression of another CDI, p21 WAF1 , have also been seen in some human tumors, including glial tumors (51), non-small The protein encoded by the Rb gene, pRb, normally plays a cell lung carcinomas (52), leiomyosarcomas (53) and breast key role as a negative regulator of the G 1 -S transition in the cell carcinomas (54). Curiously, in breast cancers high p21 WAF1 cycle by binding the transcription factor E2F and preventing it expression was associated with high tumor grade and a poor from activating the transcription of genes required for the S prognosis (54). In pancreatic cancer cells there was a correlation phase (11,12). The Rb gene is inactivated in a variety of between high expression of cyclin D1 and p21 WAF1 (55). In human cancers, but in colorectal carcinomas there is frequently addition, cyclin D1 can induce increased expression of p21 WAF1 increased expression of this gene (43, 44) . This is paradoxical through an E2F mechanism (56) . This provides another in view of the known role of Rb as a tumor suppressor gene.
example of a homeostatic feedback mechanism that is retained In a recent study we compared the levels of expression in many tumors. of pRb in normal human colorectal mucosa, adenomatous Human tumors often display loss of expression of the CDI polyps, and carcinomas by immunohistochemistry (44) . We and tumor suppressor p16 INK4a , either because of mutations in found that there was a progressive increase in the expression of pRb during the multistage process of colon carcinothe gene or transcriptional silencing due to hypermethylation For example, moderate overexpression of cyclin D1 can enhance cell growth but a high level of expression can be toxic to cells (61) . The biologic effects of various protein kinases are also dependent on the cell context and their level of expression. We encountered this phenomenon in our studies on the biologic effects of specific isoforms of protein kinase C (62) and their roles in signal transduction (63) . Table I illustrates the remarkable diversity in function of the known oncogenes and tumor suppressor genes. It should also be emphasized that many of the respective proteins interact with each other in complex networks, rather than simple linear pathways, that display cross-talk and negative or positive feedback loops, analogous to electronic circuits (10, [64] [65] [66] , and the various pathways of signal transduction can be thought of as interconnecting 'modules' (66). Therefore, the accumulated effects of the multiple mutations in cancer cells leads to bizarre types of circuitry, i.e. circuits which were not present in the original parental cell, or in any other normal cell type. As a consequence, certain proteins in a cancer cell function within a novel context, since they are linked, either upstream or downstream, to proteins they are not linked to in normal cells. For similar reasons, an increase, decrease or loss of a given protein in a tumor cell might have a different 'meaning' to a cancer cell than to a normal cell, and the experimental re-introduction of a deleted protein into a cancer cell might exert effects different from those that occur when the same protein is present and expressed in normal cells.
This formulation can help to explain certain otherwise unexpected experimental results, and may also provide reason APC, into malignant tumor cells that carry multiple mutations can profoundly inhibit growth or induce apoptosis and/or (57) . However, recent studies indicate that subsets of gastric inhibit tumorigenicity (67) (68) (69) . If, according to the current and colon cancer can display increased expression of the paradigm, these cells originally evolved into a malignant tumor p16 INK4a protein (H.Yamamoto, personal communication).
through the stepwise acquisition of several mutations, then the High levels of expression of p16INK4 have also been seen in correction of one of these mutations should have only a small human neuroblastoma cell lines (58). The significance of this inhibitory effect. We believe that these results reflect the finding remains to be determined. It is of interest that loss of altered or bizarre circuitry of cancer cells, and refer to this expression of pRb is often associated with increased expression phenomenon as 'gene hypersensitivity' (10). In our studies on of p16 INK4a , suggesting the existence of a homeostatic feedback cyclin D1 we encountered another effect which also seemed loop between these two proteins, as discussed above (44, 49, 50) .
puzzling. As mentioned above, we found that stable expression of an antisense cyclin D1 cDNA in a human esophageal cancer Overview: the role of homeostatsis in carcinogenesis, when cell line, which carries an amplified cyclin D1 gene and Yin meets Yang expresses high levels of cyclin D1, depressed cyclin D1 expression, and this was associated with a dramatic reversion The above studies indicate that in several types of human cancer there can be an increase in the expression of the tumor of the cells towards a more normal phenotype (22). Nevertheless, the residual level of cyclin D1 protein expression in the suppressor genes p27 Kip1 , p21 WAF1 , p16 INK4 or Rb. As discussed above, this may reflect, at least in part, the existence of reverted cells was considerably higher than in other rapidly growing and highly tumorigenic cells in which cyclin D1 was homeostatic feedback loops in cell circuitry that maintain an appropriate balance between growth promoting and growth not amplified or overexpressed. These findings suggest that during the original evolution of these cancer cells they became inhibitory factors. Figure 3 lists additional examples of what appear to be homeostatic feedback loops in pathways of signed 'addicted' to cyclin D1 (10) and, therefore, require high levels of this protein to maintain their cancer phenotype. A possible transduction, i.e. examples of a 'Yin/Yang' phenomenon in which a growth enhancing factor induces a growth inhibitory explanation is that these cancer cells express relatively high levels of proteins that counteract the effects of cyclin D1, for factor or visa versa. In addition, it is now apparent that the biologic effects of oncogenes and tumor suppressor genes are example Rb or one of the CDIs. Thus, even only a partial decrease in cyclin D1 in these cells would alter the stoichihighly context dependent (10,60). Examples include the ability of an activated ras gene or the transcription factor E2F to either ometry between it and the respective inhibitory proteins, thus resulting in net inhibition of cell growth (10). If this explanation enhance apoptosis or induce malignant cell transformation, depending on the cell system (60). Furthermore, the biologic is correct, then cancer cells that are addicted to cyclin D1 might be unusually susceptible to drugs that block the action effects of several oncogenes depend on their level of expression. of cyclin D1. This general model might also apply to other assess this circuitry in living cells, and also to develop mathematical models (for example, see refs 64-66) for genes that are amplified and/or overexpressed, or constitutively activated, in cancer cells. Indeed, it has been shown that analyzing the complex networks and their interactions. Hopefully, the insights obtained from this new level of analysis will pancreatic cancer cells that carry a mutated and activated k-ras gene are more dependent on the function of the k-ras gene provide even more powerful approaches to cancer prevention and treatment. for growth than pancreatic cancer cells that do not carry this mutation (70). Another example of gene addiction is the finding that erB-2 antisense oligonucleotides inhibit the proliferation of Acknowledgements breast carcinomas cells with erB-2 amplification but have no A challenging future goal is to develop novel methods to
